Elevance Health Forecast, price target & analysts
Elevance Health Target price 2025 - Analyst rating & recommendation
Elevance Health Classifications & Recommendation:
Elevance Health Price Target
| Target Price | $481.56 |
| Price | $420.94 |
| Potential |
14.40%
register free of charge
|
| Number of Estimates | 18 |
|
18 Analysts have issued a price target Elevance Health 2026 .
The average Elevance Health target price is $481.56.
This is
14.40%
register free of charge
$625.00
48.48%
register free of charge
$405.00
3.79%
register free of charge
|
|
| A rating was issued by 24 analysts: 17 Analysts recommend Elevance Health to buy, 6 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Elevance Health stock has an average upside potential 2026 of
14.40%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 176.81 | 192.67 |
| 3.19% | 8.97% | |
| Net Margin | 3.30% | 3.78% |
| 1.33% | 14.41% |
16 Analysts have issued a sales forecast Elevance Health 2025 . The average Elevance Health sales estimate is
This results in the following potential growth metrics:
9 Elevance Health Analysts have issued a net profit forecast 2025. The average Elevance Health net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 25.68 | 32.03 |
| 1.82% | 24.73% | |
| P/E | 13.14 | |
| EV/Sales | 0.62 |
9 Analysts have issued a Elevance Health forecast for earnings per share. The average Elevance Health <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the Elevance Health stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Elevance Health...
Current Elevance Health Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Argus Research |
Locked
➜
Locked
|
Locked | Jan 29 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Jan 28 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Jan 24 2025 |
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Jan 24 2025 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Jan 06 2025 |
| Mizuho |
Locked
➜
Locked
|
Locked | Nov 05 2024 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Nov 04 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Argus Research:
Locked
➜
Locked
|
Jan 29 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Jan 28 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Jan 24 2025 |
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Jan 24 2025 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Jan 06 2025 |
|
Locked
Mizuho:
Locked
➜
Locked
|
Nov 05 2024 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Nov 04 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
